Imiquimod 2.5% and 3.75% for the treatment of actinic keratoses: Two phase 3 multicenter, randomized, double-blind, placebo-controlled studies
Neil Swanson, Christina Cognata Smith, Mandeep Kaur, Gary Goldenberg
Research output: Contribution to journal › Article › peer-review
12Scopus
citations
Fingerprint
Dive into the research topics of 'Imiquimod 2.5% and 3.75% for the treatment of actinic keratoses: Two phase 3 multicenter, randomized, double-blind, placebo-controlled studies'. Together they form a unique fingerprint.